HIPAA Compliant Informed Consent Obtained from Patient Prior
to Surgery at NFGC affiliated site
What are the steps that must be taken in order to discover a
“molecular signature”
of cancer or to identify a new drug target?
Learn about the process by following the flowchart below. Click on each item to see more details about that step.
Tissue, serum, or plasma is
collected at time of surgery.
DNA/RNA
identified
Proteins
identified
Signature
identified
Signature or
drug target validated
Patent protection is sought
End product
is
made available
Potential
drug
target identified
Start
Molecular Signature Process
Current Topic
Clickable Link
Read Only
Next Slide